Perfil
El Dr. Charles Conway es director científico de Biohaven Pharmaceutical Holding Co. Ltd. Anteriormente, el Dr. Conway trabajaba como Director Asociado de Analítica Biológica en Bristol Myers Squibb Co. Se licenció en la Universidad de Missouri Central, se graduó en la Universidad de California San Diego y se doctoró en la Universidad de California, Santa Bárbara.
Antiguos cargos conocidos de Charles Conway.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Chief Tech/Sci/R&D Officer | 03/10/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2017 |
Formación de Charles Conway.
| University of Central Missouri | Undergraduate Degree |
| University of California San Diego | Graduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Empresas privadas | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Charles Conway
